DV
Dividend Vision

ROIV — Roivant Sciences Ltd.

Roivant Sciences Ltd. (ROIV)

Total return is 248.1% over the past 5.7 years, 121.3 points ahead of SPY at 126.8%. Its deepest 1-year drawdown was 12.8%.

ROIV is an equity stock that tracks Roivant Sciences Ltd., a biopharmaceutical company. The fund has a limited dividend distribution profile with no reported yield rate or regular distribution frequency. The expense ratio and asset under management data are not available, making this a less transparent option for income-focused investors; it may appeal primarily to those seeking exposure to the biotech sector rather than dividend income.

ROIV key facts

Asset type
Stock
Asset class
Equity
Inception date
12/08/2020
Distribution frequency
None
Last close
$36.20
Market cap
$26,148,093,952
Average volume
4527200.0
Beta
1.126
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.47